@article{f3b57e4318dc487483a5e58bf98de61a,
title = "Hemorrhagic Resuscitation Guided by Viscoelastography in Far-Forward Combat and Austere Civilian Environments: Goal-Directed Whole-Blood and Blood-Component Therapy Far from the Trauma Center",
abstract = "Modern approaches to resuscitation seek to bring patient interventions as close as possible to the initial trauma. In recent decades, fresh or cold-stored whole blood has gained widespread support in multiple settings as the best first agent in resuscitation after massive blood loss. However, whole blood is not a panacea, and while current guidelines promote continued resuscitation with fixed ratios of blood products, the debate about the optimal resuscitation strategy—especially in austere or challenging environments—is by no means settled. In this narrative review, we give a brief history of military resuscitation and how whole blood became the mainstay of initial resuscitation. We then outline the principles of viscoelastic hemostatic assays as well as their adoption for providing goal-directed blood-component therapy in trauma centers. After summarizing the nascent research on the strengths and limitations of viscoelastic platforms in challenging environmental conditions, we conclude with our vision of how these platforms can be deployed in far-forward combat and austere civilian environments to maximize survival.",
keywords = "Austere environment, Blood-component therapy, Far forward, Goal-directed therapy, Resuscitation, Viscoelastic testing, Whole blood",
author = "Lantry, {James H.} and Phillip Mason and Logsdon, {Matthew G.} and Bunch, {Connor M.} and Peck, {Ethan E.} and Moore, {Ernest E.} and Moore, {Hunter B.} and Neal, {Matthew D.} and Thomas, {Scott G.} and Khan, {Rashid Z.} and Laura Gillespie and Charles Florance and Josh Korzan and Preuss, {Fletcher R.} and Dan Mason and Tarek Saleh and Marsee, {Mathew K.} and Lune, {Stefani Vande} and Qamarnisa Ayoub and Dietmar Fries and Walsh, {Mark M.}",
note = "Funding Information: Conflicts of Interest: E.E.M., H.B.M., M.D.N. and M.M.W. have received research grants from Haemo-netics Inc. (Boston, MA, USA) outside the submitted work. M.M.W. has received honoraria from Alexion Pharmaceuticals (Boston, MA, USA). M.D.N. has received an honorarium from Haemonetics for a speaking engagement and research support from Janssen Pharmaceuticals (Beerse, Belgium) and Noveome (Pittsburgh, PA, USA) outside the submitted work. He has served as a consultant to Janssen and CSL Behring (King of Prussia, PA, USA), and serves on the Scientific Advisory Board of Haima Therapeutics (Cleveland, OH, USA).Disclaimer: The views expressed in this review are those of the author(s) and do not necessarily reflect the official policy or position of the Department of the Army, Department of the Navy, Department of Air Force, Department of Defense, or the United States Government. Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2022",
month = jan,
day = "1",
doi = "10.3390/jcm11020356",
language = "English (US)",
volume = "11",
journal = "Journal of Clinical Medicine",
issn = "2077-0383",
publisher = "MDPI AG",
number = "2",
}